OXCARBAZEPINE — all Canadian products
22 DINs
12 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is OXCARBAZEPINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02284316 | APO-OXCARBAZEPINE | APOTEX INC | Tablet | Oral | OXCARBAZEPINE 600 MG | Marketed | |
| 02284294 | APO-OXCARBAZEPINE | APOTEX INC | Tablet | Oral | OXCARBAZEPINE 150 MG | Marketed | |
| 02284308 | APO-OXCARBAZEPINE | APOTEX INC | Tablet | Oral | OXCARBAZEPINE 300 MG | Marketed | |
| 02560615 | JAMP OXCARBAZEPINE | JAMP PHARMA CORPORATION | Tablet | Oral | OXCARBAZEPINE 600 MG | Marketed | |
| 02560607 | JAMP OXCARBAZEPINE | JAMP PHARMA CORPORATION | Tablet | Oral | OXCARBAZEPINE 300 MG | Marketed | |
| 02560593 | JAMP OXCARBAZEPINE | JAMP PHARMA CORPORATION | Tablet | Oral | OXCARBAZEPINE 150 MG | Marketed | |
| 02439751 | OXCARBAZEPINE | JUBILANT GENERICS LIMITED | Tablet | Oral | OXCARBAZEPINE 300 MG | Approved | |
| 02439743 | OXCARBAZEPINE | JUBILANT GENERICS LIMITED | Tablet | Oral | OXCARBAZEPINE 150 MG | Approved | |
| 02439778 | OXCARBAZEPINE | JUBILANT GENERICS LIMITED | Tablet | Oral | OXCARBAZEPINE 600 MG | Approved | |
| 02242068 | TRILEPTAL 300 MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | OXCARBAZEPINE 300 MG | Marketed | |
| 02242069 | TRILEPTAL 600 MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | OXCARBAZEPINE 600 MG | Marketed | |
| 02244673 | TRILEPTAL ORAL SUSPENSION | NOVARTIS PHARMACEUTICALS CANADA INC | Suspension | Oral | OXCARBAZEPINE 60 MG | Marketed | |
| 02440733 | JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Tablet | Oral | OXCARBAZEPINE 600 MG | Cancelled Post Market | |
| 02440717 | JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Tablet | Oral | OXCARBAZEPINE 150 MG | Cancelled Post Market | |
| 02440725 | JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Tablet | Oral | OXCARBAZEPINE 300 MG | Cancelled Post Market | |
| 02312034 | NOVO-OXCARBAZEPINE | NOVOPHARM LIMITED | Tablet | Oral | OXCARBAZEPINE 300 MG | Cancelled Pre Market | |
| 02312026 | NOVO-OXCARBAZEPINE | NOVOPHARM LIMITED | Tablet | Oral | OXCARBAZEPINE 150 MG | Cancelled Pre Market | |
| 02312042 | NOVO-OXCARBAZEPINE | NOVOPHARM LIMITED | Tablet | Oral | OXCARBAZEPINE 600 MG | Cancelled Pre Market | |
| 02466317 | SANDOZ OXCARBAZEPINE | SANDOZ CANADA INCORPORATED | Tablet | Oral | OXCARBAZEPINE 600 MG | Cancelled Pre Market | |
| 02466295 | SANDOZ OXCARBAZEPINE | SANDOZ CANADA INCORPORATED | Tablet | Oral | OXCARBAZEPINE 150 MG | Cancelled Pre Market | |
| 02466309 | SANDOZ OXCARBAZEPINE | SANDOZ CANADA INCORPORATED | Tablet | Oral | OXCARBAZEPINE 300 MG | Cancelled Pre Market | |
| 02242067 | TRILEPTAL 150 MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | OXCARBAZEPINE 150 MG | Cancelled Post Market |
Browse other molecules: